CONCLUSIONS	In aspirin-treated stable CAD patients , prasugrel 5 mg in VE attenuated platelet inhibition while meeting pre-specified noninferiority criterion versus prasugrel 10 mg in NE , with significantly better PD response and fewer poor responders compared to clopidogrel 75 mg in VE .\